These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 29654033)
1. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age. Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033 [TBL] [Abstract][Full Text] [Related]
2. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit. Goldspink R; Pumipi T; Dey S; Menkes DB Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113 [TBL] [Abstract][Full Text] [Related]
3. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness? Perera C; Patterson S; Bruxner G Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123 [TBL] [Abstract][Full Text] [Related]
4. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? Macfarlane A; Greenhalgh T BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057 [TBL] [Abstract][Full Text] [Related]
5. Valproate in acute mania: is our practice evidence based? Vasudev K; Mead A; Macritchie K; Young AH Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007 [TBL] [Abstract][Full Text] [Related]
6. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study. Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478 [TBL] [Abstract][Full Text] [Related]
7. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data]. Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910 [TBL] [Abstract][Full Text] [Related]
8. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines. Vasudev K; Mead A Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523 [No Abstract] [Full Text] [Related]
9. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. Hayes J; Prah P; Nazareth I; King M; Walters K; Petersen I; Osborn D PLoS One; 2011; 6(12):e28725. PubMed ID: 22163329 [TBL] [Abstract][Full Text] [Related]
10. Should women of childbearing potential be prescribed valproate? a call to action. Balon R; Riba M J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420 [TBL] [Abstract][Full Text] [Related]
11. Brief intervention reduces prescription of sodium valproate in women of childbearing age. Goldspink R; Pumipi T; Menkes DB Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997 [TBL] [Abstract][Full Text] [Related]
12. Valproate prescription prevalence among women of childbearing age. Wisner KL; Leckman-Westin E; Finnerty M; Essock SM Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103 [TBL] [Abstract][Full Text] [Related]
13. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. James L; Barnes TR; Lelliott P; Taylor D; Paton C J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432 [TBL] [Abstract][Full Text] [Related]
14. Sodium valproate and the fetus: a case study and review of the literature. Smith J; Whitehall J Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633 [TBL] [Abstract][Full Text] [Related]
15. Lithium in bipolar and other affective disorders: prescribing practice in the UK. Paton C; Barnes TR; Shingleton-Smith A; McAllister-Williams RH; Kirkbride J; Jones PB; McIntyre S; J Psychopharmacol; 2010 Dec; 24(12):1739-46. PubMed ID: 20488832 [TBL] [Abstract][Full Text] [Related]
16. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present. GarcĂa-Portilla MP; Bobes J Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547 [No Abstract] [Full Text] [Related]
17. Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG). Buoli M; Gattoni E; Collantoni E; Monteleone AM; Solmi M; Longo L; Ribolsi M; Santambrogio J; Bersani FS; Aguglia A; Serafini G; Signorelli MS; Dell'Osso B; Luciano M; Galderisi S Int J Psychiatry Clin Pract; 2021 Mar; 25(1):82-89. PubMed ID: 33380246 [TBL] [Abstract][Full Text] [Related]
18. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047 [TBL] [Abstract][Full Text] [Related]
19. Monitoring lithium therapy: the impact of a quality improvement programme in the UK. Paton C; Adroer R; Barnes TR Bipolar Disord; 2013 Dec; 15(8):865-75. PubMed ID: 24119180 [TBL] [Abstract][Full Text] [Related]
20. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder. Al Jurdi RK; Marangell LB; Petersen NJ; Martinez M; Gyulai L; Sajatovic M Am J Geriatr Psychiatry; 2008 Nov; 16(11):922-33. PubMed ID: 18978253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]